[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:merkel-cell-carcinoma:programmed-cell-death-1-ligand-1":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Merkel Cell Carcinoma","Programmed Cell Death 1 Ligand 1",4,[8,16,23,29],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06021626","A Study of CRD3874-SI in People With Solid Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:16:32.589113Z","2026-07-05T05:32:16.744495Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07115043","A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors",[20],"Phase 1\u002FPhase 2","2026-08-26T02:15:56.561131Z","2026-05-05T02:43:29.700642Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05267626","Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer",[20],"2026-08-26T02:19:18.331180Z","2026-05-05T02:43:28.878293Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":14,"content_modified":33},"NCT05859074","A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer",[12],"2026-05-05T02:43:27.807952Z"]